Heal Psoriasis

Learn

Psoriasis Diet: What the Evidence Actually Says

Last revised 2026-09-05

The short answer

Your dermatologist may have told you diet has nothing to do with psoriasis. That was the standard line for decades, and it has not survived the last fifteen years of trial data.

But the useful answer is not "diet works." It is: four dietary changes have randomised or large-cohort human evidence with skin endpoints, and they are not equally supported. Ranked by what has actually been measured:

  1. Losing weight, if you carry excess weight. The strongest evidence by a distance, including trials showing it makes existing medication work better.
  2. A Mediterranean pattern. A 35,000-person cohort and a 2025 randomised trial.
  3. Shifting the omega-6 to omega-3 ratio. Strong mechanism, real but modest trial results — and the book is candid that the trial that would settle it has never been run.
  4. Removing gluten — but only if you test positive for anti-gliadin antibodies. Good evidence in that subgroup, and the book says plainly it may do nothing for the other 86%.

Everything past that — elimination diets, nightshades, specific supplement stacks — is mechanism plus personal trial-and-error. Not worthless, but not the same thing, and you should know which one you are doing.

Nothing here is an alternative to prescribed treatment. If you are on a biologic, methotrexate or a steroid, keep taking it as prescribed while you change what you eat.

1. Weight loss — the best-evidenced dietary intervention in psoriasis

Chapter 15 of Heal Psoriasis is built on this, and the trials it cites are the strongest in the whole diet literature.

That last pair is the finding that should change behaviour. Weight loss did not merely correlate with better outcomes — it amplified the treatment people were already on. Chapter 15 gives the mechanism: leptin rises with fat mass and drives Th17 differentiation through STAT3, while adiponectin, which suppresses TNF-alpha and Th17, falls. Your fat tissue is producing hormones that oppose the drug. This has nothing to do with willpower.

The threshold is lower than people assume. In Gisondi's trial, a 7% reduction in body weight more than doubled the response rate. You do not need to reach a "normal" BMI for this to register.

2. The Mediterranean pattern

Two data points, both cited in Chapter 10:

Chapter 15 adds a case-control study in which extra-virgin olive oil and fish consumption independently predicted lower severity scores and lower C-reactive protein.

The Mediterranean pattern does several things at once — fewer calories, more omega-3s, more polyphenols and fibre, less ultra-processed food. That makes the effect hard to attribute to any one component, and easy to actually follow. For most people it is the sensible default.

3. The fat ratio — strong mechanism, honest uncertainty

Chapter 13 is the most mechanistically interesting chapter in the book, and also the one that is most upfront about what has not been proven.

Inflammation does not burn out. It is actively switched off by a class of molecules Charles Serhan's lab identified over four decades — lipoxins, resolvins, protectins and maresins, collectively specialised pro-resolving mediators (SPMs). Three of those four families need EPA and DHA as raw material. If your cell membranes are short of omega-3s, you physically cannot build most of your body's resolution molecules.

Meanwhile the food supply moved. Chapter 13 cites the numbers: US soybean oil consumption rose more than a thousand-fold between 1909 and 1999, and the dietary omega-6 to omega-3 ratio went from roughly 1:1 to somewhere between 15:1 and 25:1. The measured consequence in psoriasis is that a 2018 analysis including Serhan, a 2022 review and a 2025 systematic review all found the same tilt — pro-inflammatory mediators up, SPMs down.

And then the honest part. Two 2019 meta-analyses of omega-3 supplementation in psoriasis found effects the book itself calls "modest" and "variable." Chapter 13 does not hide behind that: it argues the trials used low doses (1–2g EPA+DHA), ran 8–12 weeks and did not control omega-6 intake at all — then states outright that the trial which would actually test the hypothesis, high-dose omega-3 plus aggressive omega-6 reduction over 6–12 months with membrane monitoring, has never been run.

That is the right confidence level to hold. The mechanism is strong. The proof is not in yet.

The practical version: cut the industrial seed oils (soybean, corn, sunflower, safflower, cottonseed, grapeseed), cook with olive oil, avocado oil, butter or ghee, and eat fatty fish several times a week. The Omega-3 Index blood test measures what actually reached your cell membranes — target 8%, against an American average of 4–5%. Expect three to six months of change before it moves.

4. Gluten — with a test first

Chapter 10's evidence is specific to a subgroup, and the book says so.

In a 2000 study, 73% of psoriasis patients who tested positive for anti-gliadin antibodies improved on a gluten-free diet over three months. Another found those antibodies in 14% of psoriasis patients against 2% of controls. The book's own conclusion: for the other 86%, removing gluten may offer no benefit. A blood test tells you which group you are in.

A caution the book does not give you. Coeliac and gliadin antibody blood tests only return reliable results while you are still eating gluten. If you eliminate first and test later, you can get a false negative and have to eat gluten again for weeks to get a usable answer. Chapter 3 puts coeliac odds in psoriasis at over double the general population and Chapter 18's Phase 1 removes gluten — but the book never connects those two facts. Test before you eliminate. This point is ours, not the book's, and it is on the corrections page.

The elimination diet, and two things it does not tell you

Chapter 18's Phase 1 runs an anti-inflammatory elimination diet for four weeks. Out: gluten, dairy, eggs, corn, soy, nightshades, legumes, alcohol, caffeine, processed sugar and seed oils. In: wild fish, pasture-raised meat, vegetables other than nightshades, olive/avocado/coconut oil, berries and bone broth.

Two honest problems with running it as written.

It has no vegetarian or vegan version. The words never appear in the book. Phase 1 removes eggs, dairy and legumes and tells you to eat fish and meat, which leaves a plant-based reader with almost nothing — and two of the book's own headline case studies (Bonjour 2021, Lewandowska 2021) are plant-based recoveries the book's protocol cannot accommodate. The free Protocol Without Meat tool works out the adaptations and states what each costs. It exists because the book does not cover this, not because it covers it elsewhere.

There is no reintroduction order anywhere in the book. Chapter 20 says "systematic reintroduction, one at a time" and that a flare within two weeks identifies a driver; Chapter 10 says every seven days. No sequence is given. Eliminate ten foods for a month and you will need a plan for putting them back that the book does not supply — putting them back all at once wastes the month.

Why vegetables, mechanistically

This part of the diet argument is usually hand-waved. The book has an answer for it, and it comes from two receptors with approved drugs pointed at them.

Chapter 14 describes the aryl hydrocarbon receptor (AHR). Activated in skin cells, it promotes the barrier proteins filaggrin and loricrin, suppresses Th17 differentiation and promotes Tregs. Its natural ligands include tryptophan metabolites, indoles made by gut bacteria, and indole-3-carbinol and DIM from cruciferous vegetables. The proof the pathway matters is pharmaceutical: tapinarof, approved in 2022, is a selective AHR-modulating cream, and in the Phase 3 PSOARING trials 40% of patients reached PASI 75 at week 12 against 6% on vehicle. Coal tar, used for a century without anyone knowing why, turns out to activate AHR too.

Chapter 8 makes the parallel case for Nrf2, the antioxidant defence switch activated by bitter plant compounds — sulforaphane, curcumin, EGCG, quercetin, allicin. Its pharmaceutical proof is dimethyl fumarate, an approved psoriasis drug that works by activating Nrf2; in the BRIDGE Phase III trial 38% of patients on it reached PASI 75 against 15% on placebo.

Neither means broccoli equals a drug — the book does not claim that and neither do we. It means there is a receptor-level reason vegetables belong in this conversation, rather than a vague appeal to "anti-inflammatory foods."

Alcohol — where the book is thinnest

Alcohol appears as a subject five times in twenty chapters: no threshold, no distinction between drink types, nothing about whether it comes back. The strongest line — "stop drinking alcohol" — sits buried in a paragraph about mouse microbiomes in Chapter 10.

The book names methotrexate a dozen times and twice calls hepatotoxic medication a reason for caution, and never once connects it to alcohol. If you take methotrexate, this question belongs with your prescriber, and it is not optional. The free Alcohol Decision tool exists to fill that gap; it deliberately does not give you a yes.

What diet cannot do

Chapter 5 offers an explanation for why the diet literature looks weaker than it is. Its model has fifteen root causes; diet touches several, but not all, and not equally in every person. Test omega-3 on 200 psoriasis patients and perhaps 40 have resolution failure as a dominant driver. Those 40 improve, the other 160 barely move, and the average publishes as "modest benefit."

That is a plausible read of the pattern. It is also close to unfalsifiable as stated, so hold it loosely: a hypothesis about why trials underperform is not a trial that succeeded.

Chapter 20 states the corollary, and it is the right note to end on. There are situations where pharmaceutical treatment alongside a lifestyle protocol is the correct call — severe disease, active psoriatic arthritis with joint damage risk, six or more months of adherence with minimal improvement, or deteriorating mental health. In its words: adding pharmaceutical support while you keep investigating causes is not failure, it is pragmatism. There is no virtue in suffering while you search.

Where to start

If the diet argument still feels abstract, the free Inflammatory Load Calculator turns one week of your current eating into a single number in about four minutes. If you are shopping under Phase 1 rules, the free Label Decoder takes a pasted ingredient list and tells you what the eliminated foods are calling themselves this week.

The full evidence, with every citation, is in **Heal Psoriasis** — Chapter 10 for gut and gluten, Chapter 13 for fats and resolution, Chapter 14 for AHR, Chapter 15 for weight and adipokines, Chapter 18 for the elimination phase itself.

This article is educational information, not medical advice. It does not diagnose, treat, or replace care from a clinician who knows your history. Never start, stop, or change a prescribed medication based on anything you read here — talk to your doctor first. Individual results vary.

Keep reading